Principal Street Partners LLC increased its position in The Cigna Group (NYSE:CI – Free Report) by 94.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,051 shares of the health services provider’s stock after acquiring an additional 995 shares during the quarter. Principal Street Partners LLC’s holdings in The Cigna Group were worth $679,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CI. Checchi Capital Advisers LLC increased its position in The Cigna Group by 0.9% during the second quarter. Checchi Capital Advisers LLC now owns 3,584 shares of the health services provider’s stock worth $1,185,000 after acquiring an additional 31 shares during the period. Benjamin F. Edwards & Company Inc. increased its holdings in shares of The Cigna Group by 1.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,206 shares of the health services provider’s stock worth $729,000 after purchasing an additional 31 shares during the period. IFG Advisors LLC raised its position in shares of The Cigna Group by 4.6% during the third quarter. IFG Advisors LLC now owns 699 shares of the health services provider’s stock valued at $242,000 after buying an additional 31 shares during the last quarter. McClarren Financial Advisors Inc. raised its position in shares of The Cigna Group by 4.7% during the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider’s stock valued at $240,000 after buying an additional 31 shares during the last quarter. Finally, Capital Investment Advisors LLC lifted its stake in shares of The Cigna Group by 2.9% in the second quarter. Capital Investment Advisors LLC now owns 1,122 shares of the health services provider’s stock valued at $371,000 after buying an additional 32 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have commented on CI. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Jefferies Financial Group raised their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. Royal Bank of Canada lowered their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, October 23rd. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $394.64.
The Cigna Group Price Performance
The Cigna Group stock traded down $0.55 on Tuesday, reaching $332.46. The company’s stock had a trading volume of 53,806 shares, compared to its average volume of 1,540,364. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The company has a market cap of $92.47 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 0.99 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The business’s fifty day moving average price is $334.74 and its 200 day moving average price is $338.63.
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same quarter in the prior year, the firm earned $6.77 EPS. The company’s revenue was up 29.8% on a year-over-year basis. Equities analysts expect that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.68%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is 52.83%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value
- How Investors Can Find the Best Cheap Dividend Stocks
- Pure Storage’s GenAI Pods and AI Trends Could Spark Recovery
- Top Stocks Investing in 5G Technology
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.